127 related articles for article (PubMed ID: 23194306)
1. BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error.
Afshar M; Deroide F; Robson A
J Cutan Pathol; 2013 Feb; 40(2):259-64. PubMed ID: 23194306
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
Goto K; Ishikawa M; Hamada K; Muramatsu K; Naka M; Honma K; Sugino T
Am J Dermatopathol; 2021 Nov; 43(11):781-787. PubMed ID: 33767067
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma.
Mahalingam M; Richards JE; Selim MA; Muzikansky A; Hoang MP
Hum Pathol; 2012 Aug; 43(8):1265-72. PubMed ID: 22285043
[TBL] [Abstract][Full Text] [Related]
4. [Eccrine porocarcinoma of the scalp].
Ekmekcı S; Lebe B
Turk Patoloji Derg; 2013; 29(2):156-9. PubMed ID: 23661356
[TBL] [Abstract][Full Text] [Related]
5. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
[TBL] [Abstract][Full Text] [Related]
6. Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient.
Gerber PA; Schulte KW; Ruzicka T; Bruch-Gerharz D
Dermatology; 2008; 216(3):229-33. PubMed ID: 18182815
[TBL] [Abstract][Full Text] [Related]
7. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
9. CK7 expression in primary cutaneous squamous cell carcinoma.
Pulitzer M; Desman G; Busam KJ
J Cutan Pathol; 2010 Sep; 37(9):966-72. PubMed ID: 20528966
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological Expression of p16INK4a is Commonly Present Both in Benign and Malignant Sweat Gland Neoplasias.
Tsujita J; Kaku Y; Ichiki T; Eto A; Maemura H; Otsuka A; Nakaie R; Kitagawa N; Morioka Y; Matsuda T; Yoshida M; Furue M
Fukuoka Igaku Zasshi; 2015 Dec; 106(12):323-9. PubMed ID: 27159948
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in sweat gland tumors.
Biernat W; Woźniak L
Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
[TBL] [Abstract][Full Text] [Related]
12. Basal Cell Carcinoma and Eccrine Porocarcinoma of the Eyelid.
Shoji MK; Tran AQ; Lazzarini TA; Choi CJ; Tse BC
Ophthalmic Plast Reconstr Surg; 2021 Mar-Apr 01; 37(2):e53-e56. PubMed ID: 32618820
[TBL] [Abstract][Full Text] [Related]
13. [A case report of eccrine porocarcinoma].
Fumo G; Piras V; Pilloni L; Ferreli C; Pau M
Clin Ter; 2015; 166(4):e273-5. PubMed ID: 26378762
[TBL] [Abstract][Full Text] [Related]
14. Mucin-producing sweat gland carcinoma of the eyelid: diagnostic and prognostic considerations.
Hoguet A; Warrow D; Milite J; McCormick SA; Maher E; Della Rocca R; Della Rocca D; Goldbaum A; Milman T
Am J Ophthalmol; 2013 Mar; 155(3):585-592.e2. PubMed ID: 23218693
[TBL] [Abstract][Full Text] [Related]
15. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
Boussahmain C; Mochel MC; Hoang MP
Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
[TBL] [Abstract][Full Text] [Related]
16. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
17. Break a sweat in the diagnosis and management of a flesh-colored nodule.
Kwah YC; Husain A
J Am Geriatr Soc; 2012 Jan; 60(1):164-5. PubMed ID: 22239302
[No Abstract] [Full Text] [Related]
18. Metastatic eccrine porocarcinoma.
Rehal B; Merin MR; Barr K
Cutis; 2013 Aug; 92(2):67-70. PubMed ID: 24087778
[TBL] [Abstract][Full Text] [Related]
19. Engrailed Homeobox 1 and Cytokeratin 19 Are Independent Diagnostic Markers of Eccrine Porocarcinoma and Distinguish It From Squamous Cell Carcinoma.
Miura K; Akashi T; Namiki T; Hishima T; Bae Y; Sakurai U; Murano K; Shiraishi J; Warabi M; Tanizawa T; Tanaka M; Bhunchet E; Kumagai J; Ayabe S; Sekiya T; Ando N; Shintaku H; Kinowaki Y; Tomii S; Kirimura S; Kayamori K; Yamamoto K; Ito T; Eishi Y
Am J Clin Pathol; 2020 Sep; 154(4):499-509. PubMed ID: 32556098
[TBL] [Abstract][Full Text] [Related]
20. A case of eccrine porocarcinoma: A treacherous mimic and diagnostic challenge.
Das D; Datta C; Chatterjee U; De A
Indian J Pathol Microbiol; 2021; 64(1):186-188. PubMed ID: 33433439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
